RNA combination therapy for lung cancer offers promise for personalized medicine
Small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), offer tremendous potential as new therapeutic agents to inhibit ...
Month: August 2014
A new way to model cancer
Sequencing the genomes of tumor cells has revealed thousands of mutations associated with cancer. One way to discover the role ...
-
Small NIH study reveals how immune response triggered by COVID-19 may damage the brain
-
Scientists discover cancer trigger that could spur targeted drug therapies
-
Researchers uncover life’s power generators in the Earth’s oldest groundwaters
-
COVID-19 fattens up our body’s cells to fuel its viral takeover
-
Study shows convalescent plasma doesn’t benefit severely ill patients hospitalized with COVID-19
-
Do early therapies help very young children with or at high likelihood for autism?